title: [Telithromycin: a new therapeutic option for community-acquired respiratory infection].
authors.affiliation: Servicio de Farmacología Clínica, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra.
authors.forename: M J
authors.initials: MJ
authors.lastname: Muñoz
authors.forename: J R
authors.initials: JR
authors.lastname: Azanza
authors.forename: M
authors.initials: M
authors.lastname: Escolar
authors.forename: A
authors.initials: A
authors.lastname: Macaya
authors.forename: F J
authors.initials: FJ
authors.lastname: Gil
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D017326:Clinical Trials, Phase III as Topic; D017714:Community-Acquired Infections / Q000188:drug therapy*; D000075202:Contraindications; D004347:Drug Interactions; D006801:Humans; D048628:Ketolides; D008133:Long QT Syndrome / Q000139:chemically induced; D018942:Macrolides; D015394:Molecular Structure; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D048628:Ketolides; D018942:Macrolides; C106791:telithromycin